Optiscan Imaging Ltd

Technology AU OIL

0.165AUD
0.01(6.45%)

Last update at 2024-12-19T05:11:00Z

Day Range

0.150.17
LowHigh

52 Week Range

0.070.26
LowHigh

Fundamentals

  • Previous Close 0.15
  • Market Cap137.83M
  • Volume875580
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-6.48023M
  • Revenue TTM2.99M
  • Revenue Per Share TTM0.004
  • Gross Profit TTM -1.30057M
  • Diluted EPS TTM-0.01

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -4.35150M -4.23304M -2.12669M -1.76535M -2.34412M
Minority interest - - - - -
Net income -4.35150M -4.23304M -2.12669M -1.76535M -2.05386M
Selling general administrative 3.60M 1.65M 1.67M 1.32M 1.72M
Selling and marketing expenses - - - - -
Gross profit 1.13M -2.68591M -0.41014M 0.30M 1.04M
Reconciled depreciation 0.38M 0.24M 0.24M 0.24M 0.12M
Ebit -4.31921M -4.20088M -2.07043M -1.70146M -2.63438M
Ebitda -3.94039M -3.96033M -1.83214M -1.46425M -2.51232M
Depreciation and amortization 0.38M 0.24M 0.24M 0.24M 0.12M
Non operating income net other - - - - -
Operating income -4.35035M -4.23209M -2.36443M -1.78593M -2.63438M
Other operating expenses 0.87M 0.93M 1.74M 1.82M 3.68M
Interest expense 0.03M 0.03M 0.06M 0.06M 0.06M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.03M 0.02M 0.04M 0.06M 0.00979M
Net interest income -0.00115M -0.01117M -0.03949M -0.06056M 0.00979M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.97M 1.28M 1.69M 0.77M -0.29026M
Total revenue 1.68M 1.01M 0.89M 1.19M 1.04M
Total operating expenses 6.42M 6.48M 4.61M 3.60M 3.68M
Cost of revenue 0.55M 3.70M 1.30M 0.89M 1.11M
Total other income expense net 0.94M 1.25M 1.64M 0.70M 0.29M
Discontinued operations - - - - -
Net income from continuing ops -4.35150M -4.23304M -2.12669M -1.76535M -2.34412M
Net income applicable to common shares -4.35150M -4.23304M -2.12669M -1.76535M -2.34412M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 15.63M 4.67M 7.98M 11.70M 3.44M
Intangible assets - 0.45M 0.45M - -
Earning assets - - - - -
Other current assets 5.40M 0.30M 0.11M 0.12M 0.07M
Total liab 1.76M 1.63M 1.39M 1.48M 1.90M
Total stockholder equity 13.87M 3.04M 6.59M 10.22M 1.55M
Deferred long term liab - - - - -
Other current liab 0.99M 0.90M 0.72M 0.58M 0.91M
Common stock 88.53M 71.86M 71.26M 70.94M 59.73M
Capital stock - 71.86M 71.26M 70.94M 59.73M
Retained earnings -75.23912M -70.94207M -66.89364M -62.66060M -60.54361M
Other liab - 0.02M 0.02M 0.01M 0.00488M
Good will - - - - -
Other assets - 0.00000M 0.05M 0.05M 0.05M
Cash 6.10M 0.88M 4.53M 8.44M 0.53M
Cash and equivalents - - - 8.44M 0.53M
Total current liabilities 1.75M 1.42M 1.00M 0.97M 1.24M
Current deferred revenue - -0.23169M -0.19923M -0.17209M -0.50931M
Net debt -5.88023M -0.46308M -3.98054M -7.77431M 0.63M
Short term debt 0.22M 0.23M 0.18M 0.17M 0.51M
Short long term debt - 0.04M - - 0.38M
Short long term debt total 0.22M 0.41M 0.55M 0.67M 1.16M
Other stockholder equity - -0.92128M -4.36243M -8.28163M 2.36M
Property plant equipment - 0.58M 0.61M 0.68M 0.88M
Total current assets 15.07M 3.65M 7.32M 10.97M 2.51M
Long term investments - - 0.05M 0.05M 0.05M
Net tangible assets - 2.59M 6.59M 10.22M 1.55M
Short term investments - 0.05M 0.05M - -
Net receivables 1.57M 0.98M 1.41M 1.24M 0.76M
Long term debt - - - - -
Inventory 2.00M 1.44M 1.27M 1.16M 1.15M
Accounts payable 0.54M 0.52M 0.30M 0.40M 0.34M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.58M 2.12M 2.23M 1.94M 2.36M
Additional paid in capital - - - - -
Common stock total equity - - - - 59.73M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.16M -1.02573M -0.45000M - -
Deferred long term asset charges - - - - -
Non current assets total 0.56M 1.03M 0.66M 0.73M 0.94M
Capital lease obligations - 0.37M 0.55M 0.67M 0.78M
Long term debt total - 0.18M 0.37M 0.50M 0.65M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.12686M -0.12414M -0.03087M -0.02019M 0.00549M
Change to liabilities 0.37M -0.06969M 0.04M 0.09M -0.25649M
Total cashflows from investing activities -0.12686M -0.12414M -0.03087M -0.02019M 0.00549M
Net borrowings -0.41548M -0.20015M -0.54853M 0.19M 0.20M
Total cash from financing activities -0.37448M 0.04M 10.07M 0.19M 1.61M
Change to operating activities -0.15979M 0.10M 0.00755M -0.00688M -0.05678M
Net income -4.35150M -4.23304M -2.12669M -1.76535M -2.05386M
Change in cash -3.65384M -3.91312M 7.92M -1.22608M 0.19M
Begin period cash flow 4.53M 8.44M 0.53M 1.75M 1.56M
End period cash flow 0.88M 4.53M 8.44M 0.53M 1.75M
Total cash from operating activities -3.16455M -3.83358M -2.12631M -1.39656M -1.42080M
Issuance of capital stock 0.04M 0.24M 11.04M - 1.50M
Depreciation 0.38M 0.24M 0.24M 0.24M 0.12M
Other cashflows from investing activities - - - 0.00000M 0.01000M
Dividends paid - 0.42M 0.20M 10.47M -
Change to inventory -0.16833M -0.10835M -0.00655M 0.00097M -0.26963M
Change to account receivables 0.44M -0.16893M -0.48560M -0.26065M 0.82M
Sale purchase of stock 0.04M -0.20015M -0.42329M -0.00402M -0.09475M
Other cashflows from financing activities -0.22730M -0.12414M 0.23M 0.19M 0.20M
Change to netincome 0.32M 0.41M 0.21M 0.31M 0.56M
Capital expenditures 0.13M 0.12M 0.03M 0.02M 0.00451M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.27M -0.27728M -0.49215M -0.25968M 0.84M
Stock based compensation 0.23M 0.38M 0.17M 0.29M -
Other non cash items 0.81M 0.16M -0.23790M 0.13M 2.22M
Free cash flow -3.29141M -3.95771M -2.15718M -1.41675M -0.00451M

Peer Comparison

Sector: Technology Industry: Scientific & Technical Instruments

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OIL
Optiscan Imaging Ltd
0.01 6.45% 0.17 - - 46.16 9.64 106.13 -12.1087
CDA
Codan Ltd
-0.3 1.88% 15.64 35.13 29.50 5.21 6.48 5.48 20.60
CAT
Catapult Grp Intl Ltd
-0.06 1.74% 3.38 - - 9.66 7.65 5.67 45.58
IKE
Ikegps Group Ltd
-0.015 2.86% 0.51 - - 3.88 6.86 3.71 -3.6167
SMN
Structural Monitoring Systems PLC
0.01 2.25% 0.46 - - 2.60 4.96 3.04 42.69

Reports Covered

Stock Research & News

Profile

Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States. It offers InVivage, an intra-oral endomicroscope for oral cancer imaging; InVue, a microscopic medical imaging device for precision surgery; and ViewnVivo, an endomicroscope for life sciences, pre-clinical and translational research. The company has a collaboration agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for applications in robotic surgery. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.

Optiscan Imaging Ltd

16 Miles Street, Mulgrave, VIC, Australia, 3170

Key Executives

Name Title Year Born
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D. CEO, MD & Exec. Director NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA Company Sec. NA
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D. CEO, MD & Executive Director NA
Mr. Brendan Fafiani Chief Operating Officer NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA Company Secretary NA
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D. CEO, MD & Executive Director NA
Mr. Brendan Fafiani Chief Operating Officer NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA Company Secretary NA
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D. CEO, MD & Executive Director NA
Mr. Brendan Fafiani Chief Operating Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.